hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06316622, orgStudyIdInfo id: 2021/08/42, briefTitle: Examination of The Relationshıp Between Body Mass Index And The Skin-Epidural Space Distance, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-03-08, primaryCompletionDateStruct date: 2022-10-01, completionDateStruct date: 2022-10-01, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Dokuz Eylul University, class: OTHER, descriptionModule briefSummary: Aim: The aim of the study; to investigate whether there is a relationship between body mass index (BMI), waist circumference, and abdominal subcutaneous adipose tissue and the skin-epidural space distance measured by USG., conditionsModule conditions: Anesthesia Awareness, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: relationship between body mass index and the skin epidural space distance, primaryPurpose: OTHER, maskingInfo masking: NONE, maskingDescription: relationship between body mass index and the skin epidural space distance, enrollmentInfo count: 42, type: ACTUAL, armsInterventionsModule interventions name: ultrasound, outcomesModule primaryOutcomes measure: We examined the relationships between body mass index calculated by measuring weight and height, subcutaneous fat tissue in the abdominal region and the skin-epidural space distance in the lumbar region; measured by ultrasound., eligibilityModule sex: ALL, minimumAge: 21 Years, maximumAge: 58 Years, stdAges: ADULT, contactsLocationsModule locations facility: Dokuz Eylul Unicersity, city: İzmir, state: Narlidere, zip: 35150, country: Turkey, geoPoint lat: 38.41273, lon: 27.13838, locations facility: Dokuz Eylul University, city: İzmir, country: Turkey, geoPoint lat: 38.41273, lon: 27.13838, hasResults: False
protocolSection identificationModule nctId: NCT06316596, orgStudyIdInfo id: 2011-KAEK-25 2023/09-16, briefTitle: Brain Oxygenation in Newborns Due to Neuroaksial Methods, acronym: oxygenation, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-05-01, completionDateStruct date: 2024-05-01, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Bursa Yüksek İhtisas Education and Research Hospital, class: OTHER_GOV, descriptionModule briefSummary: Epidural and spinal anesthesia techniques are frequently used all over the world in elective cesarean section operations. To evaluate the effects of epidural and spinal anesthesia techniques applied in cesarean section surgery on neonatal cerebral oxygenation using Near Infrared Spectroscopy (NIRS)., conditionsModule conditions: Cesarean Section, conditions: Pregnancy Related, conditions: Cerebral Hypoxia, conditions: Anesthesia, Regional, conditions: Oxygen Saturation, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: The research is a prospective controlled,randomized,double-blind study, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, maskingDescription: The research is a prospective, randomized, single-blind, parallel group study. In the study, the Quincke needle will be used for spinal anesthesia and the Tuoghy needle will be used for epidural anesthesia. Oxygenation will be evaluated with the help of NIRS probe in the post-cesarean newborns of pregnant women who will undergo elective cesarean section.Vitals will be monitored throughout the case with electrocardiography (ECG), non-invasive blood pressure monitoring and spO2. The amount of vasopressor agent and hydration required by the mother throughout the case will be recorded. While one anesthesiologist will monitor the anesthesia method and maternal vitals, the other anesthetist will monitor the NIRS monitoring attached to the newborn., whoMasked: PARTICIPANT, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Spinal Anesthesia, interventions name: Epidural Anesthesia, outcomesModule primaryOutcomes measure: Near İnfrared Spectroscopi, secondaryOutcomes measure: Maternal mean arterial pressure, secondaryOutcomes measure: Newborn vitalty, secondaryOutcomes measure: Newborn vitalty, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06316570, orgStudyIdInfo id: HX-A-2023044, secondaryIdInfos id: SF 2024-2-2045, type: OTHER_GRANT, domain: Capital health development research project, briefTitle: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke, acronym: TAPIS, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-12-01, completionDateStruct date: 2026-12-01, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Beijing Tiantan Hospital, class: OTHER, descriptionModule briefSummary: Early antiplatelet therapy is promising for further improvement of functional prognosis on the basis of intravenous thrombolytic therapy. The primary purpose of this multicenter, randomized, double-blind, placebo-parallel controlled trial is to evaluate the efficacy and safety of the early dual antiplatelet therapy (within 6 hours of onset ) of ticagrelor with aspirin combined with intravenous thrombolysis in improving good functional outcome (mRS score 0-1) at 90 days inpatients with ischemic stroke., conditionsModule conditions: Ischemic Stroke, Acute, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 1380, type: ESTIMATED, armsInterventionsModule interventions name: Early Dual Antiplatelet Therapy, interventions name: Placebo, outcomesModule primaryOutcomes measure: Excellent functional outcome, secondaryOutcomes measure: mRS score of 0-2 points, secondaryOutcomes measure: Distribution of mRS score, secondaryOutcomes measure: Neurologic improvement, secondaryOutcomes measure: Quality of life (EQ-5D scale), secondaryOutcomes measure: Activity of daily living (Barthel index ≥95 points), secondaryOutcomes measure: Recurrent ischemic stroke, secondaryOutcomes measure: Symptomatic intracranial hemorrhage (ECASS-III), secondaryOutcomes measure: Symptomatic intracranial hemorrhage (ECASS-III), secondaryOutcomes measure: Parenchymal hematoma type 2 (SIST-MOST), secondaryOutcomes measure: Parenchymal hematoma type 2 (SIST-MOST), secondaryOutcomes measure: Bleeding events (GUSTO), secondaryOutcomes measure: Adverse events, secondaryOutcomes measure: Severe adverse events, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06316557, orgStudyIdInfo id: HX-A-2022063, briefTitle: High-frequency rTMS on the Cerebellar to Improve Post-stroke Cognitive Impairment, acronym: HOPE, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2026-07-01, completionDateStruct date: 2027-04-01, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Beijing Tiantan Hospital, class: OTHER, descriptionModule briefSummary: The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days., conditionsModule conditions: Post-stroke Cognitive Impairment, conditions: Ischemic Stroke, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Multicenter Randomized Double-Blind Controlled Study, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 70, type: ESTIMATED, armsInterventionsModule interventions name: rTMS group, interventions name: control group, outcomesModule primaryOutcomes measure: The efficacy of rTMS in improving cognitive function of post-stroke cognitive impairment, secondaryOutcomes measure: The safety of rTMS in improving cognitive function of post-stroke cognitive impairment, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06316544, orgStudyIdInfo id: CECMed, secondaryIdInfos id: 2021ZD0111000, type: OTHER_GRANT, domain: National Science and Technology Major Project, briefTitle: China Elderly Comorbidity Medical Database, acronym: CECMed, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-03-01, primaryCompletionDateStruct date: 2024-11-30, completionDateStruct date: 2024-11-30, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Beijing Friendship Hospital, class: OTHER, collaborators name: Chinese Academy of Medical Sciences, Fuwai Hospital, collaborators name: The First Affiliated Hospital of Zhengzhou University, descriptionModule briefSummary: The objective of this observational cohort study is to provide comprehensive evaluation and early warning for elderly patients with chronic diseases. The main question it aims to answer is: How to explore effective evaluation methods for diseases in elderly patients based on the coexistence of multiple diseases and high individual heterogeneity? How to explore the key indicators and influencing factors of adverse events in elderly patients.. Participants will be followed up at 1, 3, 6, 9, and 12 months to obtain adverse event information., conditionsModule conditions: Coronary Artery Disease, conditions: Hypertension, conditions: Diabetes Mellitus, conditions: Osteoporosis, conditions: COPD Chronic Obstructive Pulmonary Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: OTHER, enrollmentInfo count: 4100, type: ESTIMATED, outcomesModule primaryOutcomes measure: Pneumonia/pulmonary infection, primaryOutcomes measure: respiratory failure, primaryOutcomes measure: pulmonary encephalopathy, primaryOutcomes measure: acute exacerbation of chronic obstructive pulmonary disease, primaryOutcomes measure: unstable angina pectoris, primaryOutcomes measure: acute myocardial infarction, primaryOutcomes measure: acute hemorrhagic stroke, primaryOutcomes measure: acute ischemic stroke, primaryOutcomes measure: acute heart failure/acute exacerbation of chronic heart failure, primaryOutcomes measure: malignant ventricular arrhythmia, primaryOutcomes measure: sudden death, primaryOutcomes measure: falls, primaryOutcomes measure: fractures, primaryOutcomes measure: gastrointestinal bleeding, primaryOutcomes measure: pulmonary embolism, primaryOutcomes measure: deep vein thrombosis, primaryOutcomes measure: diabetes ketoacidosis, primaryOutcomes measure: diabetes hyperosmolar coma, primaryOutcomes measure: rehospitalization, primaryOutcomes measure: admission to ICU, eligibilityModule sex: ALL, minimumAge: 65 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Beijing Friendship Hospital, status: RECRUITING, city: Beijing, state: Beijing, zip: 100050, country: China, contacts name: Bingbing Ke, Dr, role: CONTACT, phone: 15510286857, email: 1017120710@qq.com, contacts name: Hongwei Li, Dr, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06316531, orgStudyIdInfo id: BL-M07D1-301, briefTitle: A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2026-05, completionDateStruct date: 2026-05, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Sichuan Baili Pharmaceutical Co., Ltd., class: INDUSTRY, collaborators name: Baili-Bio (Chengdu) Pharmaceutical Co., Ltd., descriptionModule briefSummary: This study is a registered phase III, randomized, open-label, multicenter study to evaluate the efficacy and safety of BL-M07D1 in patients with unresectable locally advanced or metastatic HER2-positive breast cancer who had failed previous treatment with taxanes and trastuzumab., conditionsModule conditions: HER2-positive Breast Cancer, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 268, type: ESTIMATED, armsInterventionsModule interventions name: BL-M07D1, interventions name: T-DM1, outcomesModule primaryOutcomes measure: Progression-free survival (PFS), secondaryOutcomes measure: Overall survival (OS), secondaryOutcomes measure: Objective Response Rate (ORR), secondaryOutcomes measure: Disease Control Rate (DCR), secondaryOutcomes measure: Duration of Response (DOR), secondaryOutcomes measure: Treatment Emergent Adverse Event (TEAE), secondaryOutcomes measure: Anti-drug antibody (ADA), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Sun Yat-sen Memorial Hospital, Sun Yat-sen University, city: Guangzhou, state: Guangdong, country: China, contacts name: Erwei Song, role: CONTACT, contacts name: Erwei Song, role: PRINCIPAL_INVESTIGATOR, contacts name: Herui Yao, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 23.11667, lon: 113.25, hasResults: False
protocolSection identificationModule nctId: NCT06316518, orgStudyIdInfo id: AIBU-HF-YS-01, briefTitle: The Effect of Mindfulness-Based Web-Based Stress Reduction Program Applied to Primigravidas on Perceived Stress Level in Pregnancy, Birth Self-Efficacy and Prenatal Attachment, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2024-12-01, completionDateStruct date: 2025-05-01, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Ataturk University, class: OTHER, descriptionModule briefSummary: The aim of this study is to investigate the effect of a mindfulness-based web-based stress reduction program applied to primigravidas on perceived stress level in pregnancy, birth self-efficacy and prenatal attachment., conditionsModule conditions: Pregnancy Related, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Two groups with a supportive care control groups, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 90, type: ESTIMATED, armsInterventionsModule interventions name: mindfulness group, outcomesModule primaryOutcomes measure: Pregnancy Stress Assessment Scale (PSAS), primaryOutcomes measure: Self-Efficacy Scale for Normal Childbirth, primaryOutcomes measure: Prenatal Attachment Inventory (PAI), eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06316505, orgStudyIdInfo id: 11/2023-58, briefTitle: Oral Photographs of Patients on Oral Hygiene Motivation, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-12-01, primaryCompletionDateStruct date: 2024-03-01, completionDateStruct date: 2024-03-01, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-21, sponsorCollaboratorsModule leadSponsor name: Didem OZKAL EMINOGLU, class: OTHER, descriptionModule briefSummary: Based on these considerations, this randomized controlled trial aimed to determine the effectiveness of a personalized visual oral health education program in addition to conventional education on oral hygiene by comparing changes in clinical periodontal parameters.Participants will get conventional oral hygiene education (COHE) with/without visual motivation using self oral photographs of patients.Researchers will compare Intervention group and control groups on oral hygiene by comparing changes in clinical periodontal parameters., conditionsModule conditions: Periodontal Diseases, conditions: Motivation, conditions: Hygiene, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: TRIPLE, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 56, type: ACTUAL, armsInterventionsModule interventions name: Oral hygiene motivation with individual oral photograps, outcomesModule primaryOutcomes measure: Clinical periodontal parameters / plaque index (PI), primaryOutcomes measure: Clinical periodontal parameters / gingival index (GI), primaryOutcomes measure: Clinical periodontal parameters / probing pocket depth (PPD)., primaryOutcomes measure: Clinical periodontal parameters / bleeding on probing (BOP), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Atatürk University, city: Erzurum, zip: 25240_, country: Turkey, geoPoint lat: 39.90861, lon: 41.27694, hasResults: False
protocolSection identificationModule nctId: NCT06316492, orgStudyIdInfo id: 101919039932, briefTitle: A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Faculty of Medicine in Assiut and New Valley University to Assess Knowledge, Attitude ,and Practice of Rural Population in a Remote Governorate ( New Valley ) Towards Hepatitis B and C Viruses, acronym: rural_remote, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-08-01, primaryCompletionDateStruct date: 2024-12-01, completionDateStruct date: 2026-06-01, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: This study is a research aiming to identify knowledge, attitude and practice of population in a village in a remote governorate towards viral hepatitis B and C . It involves home visit interviews with population in this village with the use of questionnaire involving questions asked by the researcher that would be orally answered by the participants to be recorded in papers by the researcher., conditionsModule conditions: Hepatitis B, conditions: Hepatitis C, designModule studyType: OBSERVATIONAL, designInfo observationalModel: ECOLOGIC_OR_COMMUNITY, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 450, type: ESTIMATED, outcomesModule primaryOutcomes measure: Assess proportion of adequate knowledge, attitude and practice /behaviour towards viral hepatitis B and C in a rural population in New Valley Governorate, secondaryOutcomes measure: Assess proportion of high risk groups of viral hepatitis B and C in these population thus behaviours made them candidates for viral hepatitis B and C infection, secondaryOutcomes measure: 2- Proportion of health-seeking behaviour of cases ( confirmation of diagnosis, treatment, and follow up ) and proportion of high risk group seeking for screening, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06316479, orgStudyIdInfo id: CI-001-23, briefTitle: Safety and Performance of PTMC Dermal Filler, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-08, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2025-12, studyFirstPostDateStruct date: 2024-03-18, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Aqpha Medical B.V., class: INDUSTRY, descriptionModule briefSummary: The goal of this clinical trial is to assess the safety and performance of the PTMC Dermal filler for treating moderate to severe nasolabial folds in adult men and women.The main questions it aims to answer are:* Does the PTMC dermal filler maintain its performance for a minimum of 6 months?* Is the treatment considered safe for participants?Participants will:* Before treatment, the investigator will assess your medical history, medication usage, and satisfaction with your wrinkles/folds.* You'll receive one injection of the PTMC Dermal filler during your initial visit.* For 30 days post-injection, you'll keep a diary to note any reactions like pain, redness, or swelling at the injection site.* At the 1-month follow-up, you can request a 'touch-up' of the filler, extending your participation in the study.* Participants will visit the clinic a total of 8 times, including the initial treatment and 7 follow-up visits, spanning up to 18 months.* Each visit will last approximately 60-90 minutes. The visits will be conducted in person., conditionsModule conditions: Moderate to Severe Nasolabial Fold, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: PTMC Dermal Filler, outcomesModule primaryOutcomes measure: Nasolabial fold severity, secondaryOutcomes measure: Safety (Adverse events), secondaryOutcomes measure: Nasolabial fold severity, secondaryOutcomes measure: Responder rate, secondaryOutcomes measure: Overall aesthetic improvement (by the investigator), secondaryOutcomes measure: Overall aesthetic improvement (by the subject), secondaryOutcomes measure: Subject satisfaction, otherOutcomes measure: Visual Analog Scale (VAS) for pain, otherOutcomes measure: Treatment satisfaction, otherOutcomes measure: Ease of use, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 67 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False